Decreased expression of microRNA-214 contributes to imatinib mesylate resistance of chronic myeloid leukemia patients by upregulating ABCB1 gene expression. [electronic resource]
Publication details: Experimental and therapeutic medicine Sep 2018Description: 1693-1700 p. digitalISSN:- 1792-0981
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.